Mindfulness with wearables to help prevent high blood pressure problems in pregnancy
Official title: Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy Study: MINDBP
Run by Medical College of Wisconsin · NCT07218237 · Data updated 2026-11-12
This study tests whether adding mindfulness training with wearable biosensors to standard prenatal care can help prevent hypertensive disorders in pregnant people at risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Medical College of Wisconsin Academic / other |
| Locations | 2 sites (Providence, Rhode Island and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | March 1, 2028 |
| Study ends | October 1, 2028 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07218237 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant individuals ≤16 weeks gestation who are at moderate to high risk for preeclampsia and meet inclusion criteria.
✕Probably not a fit
Women with multiple gestations, pregestational hypertension, or active mind-body practices may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The MINDBP study will enroll 90 pregnant individuals at risk for hypertensive disorders of pregnancy and randomize them to three groups: mindfulness training with wearable biosensors, mindfulness training alone, or routine prenatal care. Participants in the mindfulness arms will receive eight weekly phone-based sessions with two booster sessions after the intervention, while all participants wear a Garmin Vivoactive 4. Outcomes include feasibility, fidelity, and acceptability, with physiological and psychological measures (blood pressure, heart rate, heart rate variability, perceived stress, and pregnancy-related anxiety) assessed at baseline (≤16 weeks), after the intervention (~24 weeks), and after each booster (~28 and 32 weeks). The study is conducted at two sites: Brown University and Medical College of Wisconsin, led by MCW with collaboration at Brown.
Why it matters
Potential benefit: If successful, the approach could offer a feasible way to reduce risk factors and improve well-being for at‑risk pregnancies.
How similar studies have gone: Previous work suggests mindfulness and wearables can influence stress and autonomic markers, but direct evidence for preventing hypertensive disorders in pregnancy is limited, making this study relatively novel in its combined approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant patients at gestational age \<= 16 weeks * Live, non-anomalous gestation * Normotensive at enrollment * Meet criteria consistent with 'moderate' to 'high' risk for preeclampsia based on ACOG/USPSTF guidelines for low-dose aspirin administration to prevent hypertensive disorders of pregnancy Exclusion Criteria: * Multiple gestation * Chronic (pregestational hypertension) * Inability of unwillingness to provide informed consent * Active suicidality or psychosis * Ongoing mind-body practice (e.g., yoga, meditation, mindfulness \>= once per week)
Where it's running
-
Brown University
Providence, Rhode Island, United States Recruiting -
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Anna Palatnik, MD — Medical College of Wisconsin
- Study coordinator: Anna Palatnik, MD
- Email: apalatnik@mcw.edu
- Phone: 14148056627
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Internal jugular vein collapsibility to gauge volume status in preeclampsia vs. normal pregnancy
This study tests whether ultrasound of the internal jugular vein can show differences in fluid status between preeclamptic pregnant people and those with normal blood pressure during planned cesarean delivery.
-
Higher vs lower daily aspirin in high-risk pregnant people
This study tests whether taking 150 mg of aspirin daily is more effective than 75 mg daily in preventing preeclampsia among pregnant people at high risk.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Role of Progesterone Membrane Receptors in Preeclampsia
This study looks at whether the levels of progesterone membrane receptors in the placenta differ between women with preeclampsia and healthy pregnant women to understand the condition better.
-
Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders
This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.